Cargando…

IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy

BACKGROUND AND OBJECTIVES: IgG4 autoantibodies to neurofascin-155 (Nfasc155) are associated with a subgroup of patients with chronic inflammatory demyelinating polyneuropathy (CIDP), currently named autoimmune nodopathy. We previously demonstrated that those antibodies alter conduction along myelina...

Descripción completa

Detalles Bibliográficos
Autores principales: Jentzer, Alexandre, Attal, Arthur, Roué, Clémence, Raymond, Julie, Lleixà, Cinta, Illa, Isabel, Querol, Luis, Taieb, Guillaume, Devaux, Jérôme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365386/
https://www.ncbi.nlm.nih.gov/pubmed/35948442
http://dx.doi.org/10.1212/NXI.0000000000200014
_version_ 1784765333675966464
author Jentzer, Alexandre
Attal, Arthur
Roué, Clémence
Raymond, Julie
Lleixà, Cinta
Illa, Isabel
Querol, Luis
Taieb, Guillaume
Devaux, Jérôme
author_facet Jentzer, Alexandre
Attal, Arthur
Roué, Clémence
Raymond, Julie
Lleixà, Cinta
Illa, Isabel
Querol, Luis
Taieb, Guillaume
Devaux, Jérôme
author_sort Jentzer, Alexandre
collection PubMed
description BACKGROUND AND OBJECTIVES: IgG4 autoantibodies to neurofascin-155 (Nfasc155) are associated with a subgroup of patients with chronic inflammatory demyelinating polyneuropathy (CIDP), currently named autoimmune nodopathy. We previously demonstrated that those antibodies alter conduction along myelinated axons by inducing Nfasc155 depletion and paranode destruction. In blood, IgG4 have the potency to exchange their moiety with other unrelated IgG4 through a process called Fab-arm exchange (FAE). This process results in functionally monovalent antibodies and may affect the pathogenicity of autoantibodies. Here, we examined this issue and whether FAE is beneficial or detrimental for Nfasc155 autoimmune nodopathy. METHODS: The bivalency and monospecificity of anti-Nfasc155 were examined by sandwich ELISA in 10 reactive patients, 10 unreactive CIDP patients, and 10 healthy controls. FAE was induced in vitro using reduced glutathione and unreactive IgG4, and the ratio of the κ:λ light chain was monitored. To determine the pathogenic potential of bivalent anti-Nfasc155 IgG4, autoantibodies derived from patients were enzymatically cleaved into monovalent Fab and bivalent F(ab’)(2) or swapped with unreactive IgG4 and then were injected in neonatal animals. RESULTS: Monospecific bivalent IgG4 against Nfasc155 were detected in the serum of all reactive patients, indicating that a fraction of IgG4 have not undergone FAE in situ. These IgG4 were, nonetheless, capable of engaging into FAE with unreactive IgG4 in vitro, and this decreased the levels of monospecific antibodies and modulated the ratio of the κ:λ light chain. When injected in animals, monovalent anti-Nfasc155 Fab did not alter the formation of paranodes; by contrast, both native anti-Nfasc155 IgG4 and F(ab’)(2) fragments strongly impaired paranode formation. The promotion of FAE with unreactive IgG4 also strongly diminished the pathogenic potential of anti-Nfasc155 IgG4 in animals and decreased IgG4 clustering on Schwann cells. DISCUSSION: Our findings demonstrate that monospecific and bivalent anti-Nfasc155 IgG4 are detected in patients and that those autoantibodies are the pathogenic ones. The transformation of anti-Nfasc155 IgG4 into monovalent Fab or functionally monovalent IgG4 through FAE strongly decreases paranodal alterations. Bivalency thus appears crucial for Nfasc155 clustering and paranode destruction.
format Online
Article
Text
id pubmed-9365386
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93653862022-08-11 IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy Jentzer, Alexandre Attal, Arthur Roué, Clémence Raymond, Julie Lleixà, Cinta Illa, Isabel Querol, Luis Taieb, Guillaume Devaux, Jérôme Neurol Neuroimmunol Neuroinflamm Research Article BACKGROUND AND OBJECTIVES: IgG4 autoantibodies to neurofascin-155 (Nfasc155) are associated with a subgroup of patients with chronic inflammatory demyelinating polyneuropathy (CIDP), currently named autoimmune nodopathy. We previously demonstrated that those antibodies alter conduction along myelinated axons by inducing Nfasc155 depletion and paranode destruction. In blood, IgG4 have the potency to exchange their moiety with other unrelated IgG4 through a process called Fab-arm exchange (FAE). This process results in functionally monovalent antibodies and may affect the pathogenicity of autoantibodies. Here, we examined this issue and whether FAE is beneficial or detrimental for Nfasc155 autoimmune nodopathy. METHODS: The bivalency and monospecificity of anti-Nfasc155 were examined by sandwich ELISA in 10 reactive patients, 10 unreactive CIDP patients, and 10 healthy controls. FAE was induced in vitro using reduced glutathione and unreactive IgG4, and the ratio of the κ:λ light chain was monitored. To determine the pathogenic potential of bivalent anti-Nfasc155 IgG4, autoantibodies derived from patients were enzymatically cleaved into monovalent Fab and bivalent F(ab’)(2) or swapped with unreactive IgG4 and then were injected in neonatal animals. RESULTS: Monospecific bivalent IgG4 against Nfasc155 were detected in the serum of all reactive patients, indicating that a fraction of IgG4 have not undergone FAE in situ. These IgG4 were, nonetheless, capable of engaging into FAE with unreactive IgG4 in vitro, and this decreased the levels of monospecific antibodies and modulated the ratio of the κ:λ light chain. When injected in animals, monovalent anti-Nfasc155 Fab did not alter the formation of paranodes; by contrast, both native anti-Nfasc155 IgG4 and F(ab’)(2) fragments strongly impaired paranode formation. The promotion of FAE with unreactive IgG4 also strongly diminished the pathogenic potential of anti-Nfasc155 IgG4 in animals and decreased IgG4 clustering on Schwann cells. DISCUSSION: Our findings demonstrate that monospecific and bivalent anti-Nfasc155 IgG4 are detected in patients and that those autoantibodies are the pathogenic ones. The transformation of anti-Nfasc155 IgG4 into monovalent Fab or functionally monovalent IgG4 through FAE strongly decreases paranodal alterations. Bivalency thus appears crucial for Nfasc155 clustering and paranode destruction. Lippincott Williams & Wilkins 2022-08-10 /pmc/articles/PMC9365386/ /pubmed/35948442 http://dx.doi.org/10.1212/NXI.0000000000200014 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Research Article
Jentzer, Alexandre
Attal, Arthur
Roué, Clémence
Raymond, Julie
Lleixà, Cinta
Illa, Isabel
Querol, Luis
Taieb, Guillaume
Devaux, Jérôme
IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
title IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
title_full IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
title_fullStr IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
title_full_unstemmed IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
title_short IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
title_sort igg4 valency modulates the pathogenicity of anti–neurofascin-155 igg4 in autoimmune nodopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365386/
https://www.ncbi.nlm.nih.gov/pubmed/35948442
http://dx.doi.org/10.1212/NXI.0000000000200014
work_keys_str_mv AT jentzeralexandre igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy
AT attalarthur igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy
AT roueclemence igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy
AT raymondjulie igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy
AT lleixacinta igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy
AT illaisabel igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy
AT querolluis igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy
AT taiebguillaume igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy
AT devauxjerome igg4valencymodulatesthepathogenicityofantineurofascin155igg4inautoimmunenodopathy